References
- De Belilovsky C, Ilhe F, Pernet AM. Equale study: Impact of rosacea on quality of life of affected patients. J Am Acad Dermatol. 2007;56(2) Supp.2:AB16.
- Menezes N, Moreira A, Mota G, Baptista A. Quality of life and rosacea: Pulsed dye laser impact. J Cosmet Laser Ther. 2009;11: 139–141.
- Tan ST, Bialstocki A, Armstrong JR. Pulsed dye laser therapy for rosacea. Br J Plast Surg. 2004;57:303–310.
- Tan SR, Tope WD. Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life. J Am Acad Dermatol. 2004;51:592–599.
- Maxwell EL, Ellis DAF, Manis H. Acne rosacea: Effectiveness of 532 nm laser on the cosmetic appearance of the skin. J Otolaryngol Head Neck Surg. 2010;39:292–296.
- Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, et al. Standard grading system for rosacea: Report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50:907–912.
- Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: Report of the National Rosacea Society expert committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46:584–587.
- Van Zuuren EJ, Kramer SF, Carter BR, Graber MA, Federowicz Z. Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review. Br J Dermatol. 2011;165: 760–781.
- Moustafa FA, Sandoval LF, Feldman SR. Rosacea: new and emerging treatment. Drugs. 2014;74:1457–1465.
- Del Rosso JQ. Management of cutaneous rosacea: emphasis on new medical treatments. Expert Opin Pharmacother. 2014;15(14): 2029–2038.
- Schroeter CA, Haaf-Von Below S, Neumann HAM. Effective treatment of rosacea using intense pulsed light systems. Dermatol Surg. 2005;31:1285–1289.
- Clark SM, Lanigan SW, Marks R. Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci. 2002;17: 26–33.
- Nicholson K, Abramova L, Chren MM, Yeung J, Chon SY, Chen SC. A pilot quality of life instrument for acne rosacea. J Am Acad Dermatol. 2007;57:213–221.
- Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of non- purpuragenic pulsed dye laser and intense pulsed light for erythemotelangiectatic rosacea. Dermatol Surg. 2009;35:920–928.
- Kini SP, Nicholson K, DeLong LK, Dannemann T, Estaris J, Foster J, et al. A pilot study in discrepancies in quality of life among three cutaneous types of rosacea. J Am Acad Dermatol. 2010;62: 1069–1071.
- Moustafa FA, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options. J Am Acad Dermatol. 2014;71:973–980.
- Van der Linden MMD, Van Rappard DC, Daams JG, Spranglers MAG, Spuls PI, De Korte J. Healthrelated quality of life in patients with cutaneous rosacea: a systematic review. Acta Derm Venereol. 2015; 95:395–400.
- Papageorgiou P, Clayton W, Norwood S, Chopra S, Rustin M. Treatment of rosacea with intense pulsed light: significant improvements and long-lasting results. Br J Dermatol. 2008;159:628–632.
- Huynh TT. Burden of disease: the psychological impact of rosacea on patients’ quality of life. Am Health Drug Benefits. 2013;6:348–354.
- Bohm D, Schwanitz P, Gissendanner SS, Schmid-Ott G, Schulz W. Symptom severity and psychological sequelae in rosacea: results of a survey. Psychol Health Med. 2014;19:586–591.
- Beikert FC, Langenbruch AK, Radtke MA, Augustin M. Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol. 2013;27:734–738.
- Jasim ZF, Woo WK, Handley JM. Long-pulsed (6-ms) pulsed dye laser treatment of rosacea-associated telangiectasia using sub-purpuric clinical threshold. Dermatol Surg. 2004;30:37–40.
- Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9: 169–180.
- Mark KA, Sparacio RM, Voigt A, Marenus K, Sarnoff DS. Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment. Dermatol Surg. 2003; 29:600–604.
- Shim TN, Abdullah A. The Effect of Pulsed Dye Laser on the Dermatology Quality of Life Index in Erythemotelangiectatic Rosacea Patients: An Assessment. J Clin Aesthet Dermatol. 2013;6: 30–32.
- Van Zuuren EJ, Fedorowicz Z. Lack of appropriately assessed patient reported outcomes in randomised controlled trials assessing the effectiveness of interventions for rosacea. Br J Dermatol. 2013;168:426–460.
- Aksoy B, Altaykan-Hapa A, Egemen D, Karagoz F, Atakan N. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol. 2010;163:719–725.